LYTIR

Company · BNGO

Bionano Genomics, Inc.

Nasdaq's symbol directory lists BNGO on Nasdaq as “Bionano Genomics, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($10K); 2 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $10K in total; Insider sales: $0 in total.Aug: Insider purchases $5KSep: Insider purchases $5KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $10KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Luderer Albert, Interim Chief Executive bought on 2 days latest Sep 4, 2026 bought $10K
Every trade (2)
  1. BUYLuderer Albert, Interim Chief Executive bought Sep 4, 2026 4,000 shares filing $5K
  2. BUYLuderer Albert, Interim Chief Executive bought Aug 21, 2026 4,000 shares filing $5K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Orin Hirschman filed Oct 19, 2026 Schedule 13G passive filing 9.9%
  2. CVI Investments, Inc. filed Aug 14, 2026 Schedule 13G/A passive filing 9.9%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Sep 14, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.